$44 video appointments available today with a membership as low as $15/month
Book a video appointmentOn Sunday, September 18, 2022, neurologist Dariush Saghafi, MD, presented an informative and engaging presentation on how to evaluate headaches in primary care to HealthTap’s Doctor Network. Dr. Saghafi is the Director of the Headache Clinic at Louis Stokes Cleveland Department of Veterans Affairs Medical Center in Cleveland, Ohio.
For the full presentation, titled: “Challenges in Telemedicine: The HA Patient,” you may watch a video recording of Dr. Saghafi's informative webinar.
In his talk, Dr. Saghafi went over these key points:
HealthTap doctors had quite a few questions for Dr. Saghafi. Here is a summary of the answers from Dr. Saghafi and the HealthTap team:
Discovering precise food triggers can be a daunting task in some patients though many have a good idea of the foods and beverages they need to avoid in order not to get migraine headaches. However, my general rule of thumb when explaining how to document potential triggers in a headache diary is to ask patients to be cognizant and aware of the foods or beverages they have ingested in any two-hour time period preceding migraine attacks or migraine aura.
Though this may seem to be a rather short block of time beyond which ingested foods and beverages are not considered part of the potential culprit list — in reality, studies have found that most ingested substances tend to cause reactions in migraineurs within two hours if they have relatively normal G.I. transit times and no other significant comorbid conditions that could block food absorption or the digestive process.
The two-hour timeframe also makes documentation efforts much more manageable for most patients who have busy schedules and cannot necessarily recall everything they have eaten throughout the day any longer than two hours (especially if migraine attacks follow).
The international classification of headache disorders specifically speaks to a duration of time for cluster headaches as being no shorter than 15 minutes and no longer than 180 minutes. The rapidity with which these headaches come on, reach their zenith and subside, is impressive and can be witnessed by clinicians and family members as they occur.
Typically, dysautonomia features that characterize cluster headaches such as conjunctival injection, tearing, and facial asymmetry can last the entire duration of the headache or any part thereof.
However, as a general rule of thumb, the longer the duration of the headache from start to finish the shorter the time of some of the more impressive or visibly notable symptoms such as the “red and angry eye.“ I have found that in patients with cluster headaches lasting one hour or less symptoms related to the orbit in the eye tend to run the entire course whereas patients with time frames longer than this tend to resolve their eye and/or orbital symptoms within one to two hours, though the severity of the headache itself and other sensory/autonomic changes can persist right until termination of the event.
Good management in patients suffering from mild traumatic brain injury (mTBI) should always include at the very least confrontational visual field testing in the office or bedside which can be rather sensitive in the detection of small visual field defects not otherwise noticed by patients. If such “dropouts” in visual integrity were to be discovered by the examining clinician then, more sophisticated and detailed testing using visual perimetry devices and computers can be ordered.
Although any number of imaging studies could be obtained in post-traumatic brain injury patients it is generally agreed that the best single test in such cases is the non-contrasted MRI of the brain. In post-traumatic brain injury cases, my threshold for performing an MRV is guided by other clinical parameters, such as:
Other clinical parameters I watch for are:
Even though motor weakness of a focal nature is considered to be one of the key features of aura in hemiplegic migraine, it must be noted that in some cases this weakness can be subtle and even overshadowed by other symptoms, such as:
Even though the diagnosis of hemiplegic migraine is stated to be rare, I believe it is highly underreported due to lack of relevant questioning by the clinician of the patient in terms of motor and sensory symptoms that are generally not considered part of the migraine aura phenomenon in patients who do not have hemiplegic migraine. Full and complete history-taking in a migraine patient involves asking whether or not anyone else in the bloodline suffers from not only similar headaches, but similar associated symptoms of either motor or sensory changes during their headaches, as this could be a clue to the familial hemiplegic migraine subtype.
Another key piece of history in these patients is the characteristic finding in hemiplegic migraine of onset of symptoms, typically in the teenage years and more uncommonly after their 20s or 30s, which may actually be peak years of incidence for migraine headaches with or without aura not including any hemiplegic subtype.
The most important reason to either include or exclude the diagnosis of hemiplegic migraine in any new headache patient being seen for the first time is so that the triptan family of drugs can either be considered with confidence as a possible treatment option, or avoided altogether since triptans can increase the risk of both stroke and heart attack during such episodes.
To date, the exact mechanism of action for high-flow, 100% O2 in cluster headache remains unclear, but proposed mechanisms of action seem to focus on oxygen‘s ability to modulate areas of the brain specifically targeted by cluster headache such as the trigeminovascular system, the cranial autonomic system, and perhaps most importantly, the hypothalamus.
There seems to be no question that the trigeminovascular system is a key player and highly activated during cluster headaches. As a result, neuro-inflammation can occur, which results in the release of significant amounts of neuropeptides and CGRP concentration elevations, which are all effectively countered by the oxygen treatment. High-flow O2 is believed to reduce and even terminate the effect of this inflammatory rush upon trigeminal afferents which may also explain the rapidity by which this therapy can act in cluster headaches.
Thank you to Dr. Saghafi for his fascinating presentation.